Michael L. J. Apuzzo – författare

Focusing on both the patient’s perspective and the neurosurgeon’s concerns, Intracranial Arteriovenous Malformations: Essentials for Patients and Practitioners, edited by leading experts Drs. Philip E. Stieg, Alexander A. Khalessi, and Michael L. J. Apuzzo, starts with an up-to-date approach to the matter of doctor-patient communication and moves on to the highly technical details of AVM treatment options. The first section covers communication with patients (who may well want to read it themselves); the second section is directed to neurosurgeons and other specialists caring for patients with intracranial AVMs, including those in emergency medicine, obstetrics, anesthesia, and intensive care. It offers a highly sophisticated but readable approach to the contemporary treatment of these challenging lesions.

Neurosurgery is seen as 'inaccessible' to those on the outside, even though collaboration with a variety of non-neurosurgeons is essential to advancing the field. Thus, this book answers important questions for those interested in surgery of the brain: What is the current state of affairs? Where is the field going? And, importantly, how can I be involved? A work of far-reaching appeal, this book explores the evolution and future of brain surgery, detailing key technologies that have and will shape the field of neurosurgery. Readers are led on a journey covering over five thousand years of neurosurgical history, from trepanation in Neolithic France to the understanding of neuroanatomy and finally the technological leaps in the 20th and 21st centuries. Advances such as artificial intelligence, nanotechnology, microscopy, robotics are discussed by the world's leading experts, providing non-neurosurgical readers with a framework for how they can be involved in this thrilling field.

The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases. The advances in the treatment of solid tumors have contributed significantly to the major increase in metastatic cancers to the brain. Of the primary malignant tumors of the brain, more than 50% are high-grade gliomas; the incidence has been increasing among older patients over the past decade. Major developments in new technologies in the treatment of primary brain tumors as well as metastatic disease are covered in depth. Even though management is difficult, advances are being made. This book is a concerted effort to present data regarding basic science research efforts alongside their translation into clinical practice using combined, integrated multimodal programs of treatment. Progress has been made, but innovatice approaches need to be pursued.

The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases. The advances in the treatment of solid tumors have contributed significantly to the major increase in metastatic cancers to the brain. Of the primary malignant tumors of the brain, more than 50% are high-grade gliomas; the incidence has been increasing among older patients over the past decade. Major developments in new technologies in the treatment of primary brain tumors as well as metastatic disease are covered in depth. Even though management is difficult, advances are being made. This book is a concerted effort to present data regarding basic science research efforts alongside their translation into clinical practice using combined, integrated multimodal programs of treatment. Progress has been made, but innovatice approaches need to be pursued.